{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:07:42Z","timestamp":1790633262478,"version":"4.1.0"},"reference-count":40,"publisher":"Japanese Society of Toxicology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2131\/jts.39.319","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T23:00:27Z","timestamp":1395097227000},"page":"319-330","source":"Crossref","is-referenced-by-count":54,"title":["Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis"],"prefix":"10.2131","volume":"39","author":[{"given":"Masayuki","family":"Ohbayashi","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacy, Department of Pharmacotherapeutics, School of Pharmacy, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kubota","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Department of Pharmacotherapeutics, School of Pharmacy, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kawase","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Department of Pharmacotherapeutics, School of Pharmacy, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kohyama","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Department of Pharmacotherapeutics, School of Pharmacy, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuna","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Department of Pharmacotherapeutics, School of Pharmacy, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Department of Pharmacotherapeutics, School of Pharmacy, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aumiller, V., Balsara, N., Wilhelm, J., Gunther, A. and Konigshoff, M. (2013): WNT\/beta-catenin signaling induces IL-1beta expression by alveolar epithelial cells in pulmonary fibrosis. Am. J. Respir. Cell. Mol. Biol., 49<\/b>, 96-104.","DOI":"10.1165\/rcmb.2012-0524OC"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bremnes, R.M., Veve, R., Gabrielson, E., Hirsch, F.R., Baron, A., Bemis, L., Gemmill, R.M., Drabkin, H.A. and Franklin, W.A. (2002): High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J. Clin. Oncol., 20<\/b>, 2417-2428.","DOI":"10.1200\/JCO.2002.08.159"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bucala, R., Spiegel, L.A., Chesney, J., Hogan, M. and Cerami, A. (1994): Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med., 1<\/b>, 71-81.","DOI":"10.1007\/BF03403533"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Carson, C.W., Cannon, G.W., Egger, M.J., Ward, J.R. and Clegg, D.O. (1987): Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin. Arthritis Rheum., 16<\/b>, 186-195.","DOI":"10.1016\/0049-0172(87)90021-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen, X.F., Zhang, H.J., Wang, H.B., Zhu, J., Zhou, W.Y., Zhang, H., Zhao, M.C., Su, J.M., Gao, W., Zhang, L., Fei, K., Zhang, H.T. and Wang, H.Y. (2012): Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K\/Akt and MEK\/Erk1\/2 signaling pathways. Mol. Biol. Rep., 39<\/b>, 3549-3556.","DOI":"10.1007\/s11033-011-1128-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Colomiere, M., Ward, A.C., Riley, C. and Trenerry, M.K., Cameron-Smith, D., Findlay, J., Ackland, L. and Ahmed, N. (2009): Cross talk of signals between EGFR and IL-6R through JAK2\/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br. J. Cancer., 100<\/b>, 134-144.","DOI":"10.1038\/sj.bjc.6604794"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Desmouliere, A. (1995): Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol. Int., 19<\/b>, 471-476.","DOI":"10.1006\/cbir.1995.1090"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Desmouliere, A., Darby, I.A. and Gabbiani, G. (2003): Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab. Invest., 83<\/b>, 1689-1707.","DOI":"10.1097\/01.LAB.0000101911.53973.90"},{"key":"9","unstructured":"Gispen, J.G., Alarcón, G.S., Johnson, J.J., Acton, R.T., Barger, B.O. and Koopman, W.J. (1987): Toxicity to methotrexate in rheumatoid arthritis. J. Rheumatol., 14<\/b>, 74-79."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hashimoto, N., Jin, H., Liu, T., Chensue, S.W. and Phan, S.H. (2004): Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest., 113<\/b>, 243-252.","DOI":"10.1172\/JCI200418847"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Imokawa, S., Colby, T.V., Leslie, K.O. and Helmers, R.A. (2000): Methotrexate pneumonitis: Review of the literature and histopathological findings in nine patients. Eur. Respir. J., 15<\/b>, 373-381.","DOI":"10.1034\/j.1399-3003.2000.15b25.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kalluri, R. and Neilson, E.G. (2003): Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest., 112<\/b>, 1776-1784.","DOI":"10.1172\/JCI200320530"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kim, K.K., Kugler, M.C., Wolters, P.J., Robillard, L., Galvez, M.G., Brumwell, A.N., Sheppard, D. and Chapman, H.A. (2006): Alveolar epithelial cell mesenchymal transition develops in vivo<\/i> during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. USA, 103<\/b>, 13180-13185.","DOI":"10.1073\/pnas.0605669103"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Koyama, S., Sato, E., Takamizawa, A., Tsukadaira, A., Haniuda, M., Kurai, M., Numanami, H., Nagai, S. and Izumi, T. (2003): Methotrexate stimulates lung epithelial cells to release inflammatory cell chemotactic activities. Exp. Lung Res., 29<\/b>, 91-111.","DOI":"10.1080\/01902140303768"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Kremer, J.M., Alarcón, G.S., Weinblatt, M.E., Kaymakcian, M.V., Macaluso, M., Cannon, G.W., Palmer, W.R., Sundy, J.S., St Clair, E.W., Alexander, R.W., Smith, G.J. and Axiotis, C.A. (1997): Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: A multicenter study with literature review. Arthritis Rheum., 40<\/b>, 1829-1837.","DOI":"10.1002\/art.1780401016"},{"key":"16","unstructured":"Kremer, J.M., Galivan, J., Streckfuss, A. and Kamen, B. (1986): Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum., 29<\/b>, 832-835."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kuwana, M., Okazaki, Y., Kodama, H., Izumi, K., Yasuoka, H., Ogawa, Y., Kawakami, Y. and Ikeda, Y. (2003): Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J. Leukoc. Biol., 74<\/b>, 833-845.","DOI":"10.1189\/jlb.0403170"},{"key":"18","unstructured":"Kuwano, K. (2007): Epithelial cell apoptosis and lung remodeling. Cell Mol. Immunol., 4<\/b>, 419-429."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Lekkerkerker, A.N., Aarbiou, J., van Es, T. and Janssen, R.A. (2012): Cellular players in lung fibrosis. Curr. Pharm. Des., 18<\/b>, 4093-4102.","DOI":"10.2174\/138161212802430396"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Liu, J., Hu, G., Chen, D., Gong, A.Y., Soori, G.S., Dobleman, T.J. and Chen, X.M. (2013): Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncogenesis., 2<\/b>, e73. doi: 10.1038\/oncsis.2013.37.","DOI":"10.1038\/oncsis.2013.37"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Liu, Y. (2004): Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol., 15<\/b>, 1-12.","DOI":"10.1097\/01.ASN.0000106015.29070.E7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Milara, J., Peiro, T., Serrano, A. and Cortijo, J. (2013): Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax., 68<\/b>, 410-420.","DOI":"10.1136\/thoraxjnl-2012-201761"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Namba, T., Tanaka, K.I., Ito, Y., Hoshino, T., Matoyama, M., Yamakawa, N., Isohama, Y., Azuma, A. and Mizushima, T. (2010): Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis. Cell Death Differ., 17<\/b>, 1882-1895.","DOI":"10.1038\/cdd.2010.64"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Nightingale. J., Patel, S., Suzuki, N., Buxton, R., Takagi, K.I., Suzuki, J., Sumi, Y., Imaizumi, A., Mason, R.M. and Zhang, Z. (2004): Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak\/Stat pathway activation. J. Am. Soc. Nephrol., 15<\/b>, 21-32.","DOI":"10.1097\/01.ASN.0000102479.92582.43"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Ohbayashi, M., Suzuki, M., Yashiro, Y., Fukuwaka, S., Yasuda, M., Kohyama, N., Kobayashi, Y. and Yamamoto T. (2010): Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo<\/i> and in vitro<\/i>. J. Toxicol. Sci., 35<\/b>, 653-661.","DOI":"10.2131\/jts.35.653"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Ohbayashi, M., Yamamoto, C., Shiozawa, A., Kohyama, N., Kobayashi, Y. and Yamamoto, T. (2013): Differential mRNA expression and the uptake of methotrexate in primary MAEC and MlF cells: involvement of the Abc and Slco\/Oatp transporters in alveolar epithelial cell toxicity. J. Toxicol. Sci., 38<\/b>, 103-114.","DOI":"10.2131\/jts.38.103"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Postlethwaite, A.E., Shigemitsu, H. and Kanangat, S. (2004): Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr. Opin. Rheumatol., 16<\/b>, 733-738.","DOI":"10.1097\/01.bor.0000139310.77347.9c"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Sampson A.P. (2000): The role of eosinophils and neutrophils in inflammation. Clin. Exp. Allergy, 1<\/b>, 22-27.","DOI":"10.1046\/j.1365-2222.2000.00092.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Schneider, D.J., Wu, M., Le, T.T., Cho, S.H., Brenner, M.B., Blackburn, M.R. and Agarwal, S.K. (2012): Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-beta production and epithelial to mesenchymal transition. FASEB J., 26<\/b>, 503-512.","DOI":"10.1096\/fj.11-186098"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Scotton, C.J. and Chambers, R.C. (2007): Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest., 132<\/b>, 1311-1321.","DOI":"10.1378\/chest.06-2568"},{"key":"31","doi-asserted-by":"crossref","unstructured":"St Clair, E.W., Rice, J.R. and Snyderman, R. (1985): Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch. Intern. Med., 145<\/b>, 2035-2038.","DOI":"10.1001\/archinte.1985.00360110105023"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Sullivan, N.J., Sasser, A.K., Axel, A.E., Vesuna, F., Raman, V., Ramirez, N., Oberyszyn, T.M. and Hall, B.M. (2009): Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene., 28<\/b>, 2940-2947.","DOI":"10.1038\/onc.2009.180"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhang, H., Tang, L., Chen, H., Wu, C., Zhao, M., Yang, Y., Chen, X. and Liu, G. (2013): Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology, 303<\/b>, 139-146.","DOI":"10.1016\/j.tox.2012.09.017"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Willis, B.C. and Borok, Z. (2007): TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell Mol. Physiol., 293<\/b>, L525-534.","DOI":"10.1152\/ajplung.00163.2007"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Willis, B.C., Liebler, J.M., Luby-Phelps, K., Nicholson, A.G., Crandall, E.D., du Bois, R.M. and Borok, Z. (2005): Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol., 166<\/b>, 1321-1332.","DOI":"10.1016\/S0002-9440(10)62351-6"},{"key":"36","unstructured":"Xie, G., Yao, Q., Liu, Y., Du, S., Liu, A., Guo, Z., Sun, A., Ruan, J., Chen, L., Ye, C. and Yuan, Y. (2012): IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures. Int. J. Oncol., 40<\/b>, 1171-1179."},{"key":"37","doi-asserted-by":"crossref","unstructured":"Xu, J., Lamouille, S. and Derynck, R. (2009): TGF-beta-induced epithelial to mesenchymal transition. Cell Res., 19<\/b>, 156-172.","DOI":"10.1038\/cr.2009.5"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Yoshida, S., Onuma, K., Akahori, K., Sakamoto, H., Yamawaki, Y., Shoji, T., Nakagawa, H., Hasegawa, H. and Amayasu, H. (1999): Elevated levels of IL-8 in interstitial pneumonia induced by low-dose methotrexate. J. Allergy Clin. Immunol., 103<\/b>, 952-954.","DOI":"10.1016\/S0091-6749(99)70445-8"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Zeisberg, E.M., Tarnavski, O., Zeisberg, M., Dorfman, A.L., McMullen, J.R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W.T., Roberts, A.B., Neilson, E.G., Sayegh, M.H., Izumo, S. and Kalluri, R. (2007): Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med., 13<\/b>, 952-961.","DOI":"10.1038\/nm1613"},{"key":"40","unstructured":"Zisman, D.A., McCune, W.J., Tino, G. and Lynch Iii, J.P. (2001): Drug-induced pneumonitis: The role of methotrexate. Sarcoidosis Vasc. Diffuse. Lung Dis., 18<\/b>, 243-252."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/39\/2\/39_319\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:39:40Z","timestamp":1620963580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/39\/2\/39_319\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.39.319","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}